Bicara Therapeutics grants 191,425 inducement stock options priced at $28.91 per share

Bicara Therapeutics Inc.

Bicara Therapeutics Inc.

BCAX

0.00
  • Bicara Therapeutics granted inducement stock options on July 1, 2026 to four new employees covering 191,425 shares.
  • Options carry a USD 28.91 exercise price, matching the Nasdaq closing price on July 1.
  • Vesting: 25% on the first anniversary of each employee’s start date, remainder in 12 equal quarterly installments, subject to continued service.
  • Awards were issued under the board-adopted 2026 Inducement Plan, outside stockholder-approved equity incentive plans.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bicara Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607020830PRIMZONEFULLFEED9756133) on July 02, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.